When you give your veins a boost of nitric oxide from a medicine like glyceryl trinitrate, it helps relax them and counteracts a tightening chemical called endothelin-1. But your body’s own nitric oxide doesn’t seem to do much to stop that tightening, because blocking its production doesn’t make the veins tighten more.

In healthy human volunteers, compare venous constriction responses to endothelin-1 infusion under three conditions: (1) placebo, (2) topical or IV glyceryl trinitrate (to externally supply NO), and (3) NG-monomethyl-L-arginine infusion (to inhibit endogenous NO). Measure venous diameter via venous occlusion plethysmography or high-resolution ultrasound before and after each intervention. Duration: single-session, 2–4 hours per condition, with washout periods.

In human forearm vein preparations (via cannulation), measure venoconstriction response to endothelin-1 before and after local infusion of glyceryl trinitrate (exogenous NO donor) and then after local infusion of NG-monomethyl-L-arginine. Compare the magnitude of constriction under each condition. Use a within-subject design with contralateral arm controls. Duration: single-session, 90–120 minutes.

Obtain human subcutaneous vein segments from elective surgery patients. Mount rings in organ baths, pre-contract with endothelin-1, then test relaxation response to exogenous NO donors (e.g., sodium nitroprusside) and assess whether pre-treatment with NG-monomethyl-L-arginine alters the degree of constriction. Compare relaxation efficacy between conditions. Duration: tissue experiments completed within 4 hours of harvest.

Measure plasma or urinary nitrite/nitrate (NO metabolites) and venous reactivity to endothelin-1 in a cohort of healthy humans. Correlate endogenous NO levels with the degree of venoconstriction. Control for confounders (e.g., smoking, BP, endothelial function). Duration: single visit per participant.